Page last updated: 2024-10-22

ambroxol and Disease Exacerbation

ambroxol has been researched along with Disease Exacerbation in 3 studies

Ambroxol: A metabolite of BROMHEXINE that stimulates mucociliary action and clears the air passages in the respiratory tract. It is usually administered as the hydrochloride.

Research Excerpts

ExcerptRelevanceReference
"The use of Ambroxol in COPD exacerbations corrected AOF production in the blood of the patients and enhanced the efficiency of their treatment."2.75[Effect of mucolytic therapy on the production of reactive oxygen species in the blood of patients with an exacerbation of chronic obstructive pulmonary disease]. ( Farkhutdinov, RR; Farkhutdinov, ShU; Farkhutdinov, UR; Mirkhaĭdarov, AM; Petriakov, VV, 2010)

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's2 (66.67)24.3611
2020's1 (33.33)2.80

Authors

AuthorsStudies
Bouscary, A1
Quessada, C1
René, F1
Spedding, M1
Henriques, A1
Ngo, S1
Loeffler, JP1
Cazzola, M1
Rogliani, P1
Calzetta, L1
Hanania, NA1
Matera, MG1
Farkhutdinov, UR1
Farkhutdinov, RR1
Petriakov, VV1
Farkhutdinov, ShU1
Mirkhaĭdarov, AM1

Reviews

2 reviews available for ambroxol and Disease Exacerbation

ArticleYear
Drug repositioning in neurodegeneration: An overview of the use of ambroxol in neurodegenerative diseases.
    European journal of pharmacology, 2020, Oct-05, Volume: 884

    Topics: Ambroxol; Amyotrophic Lateral Sclerosis; Animals; beta-Glucosidase; Disease Models, Animal; Disease

2020
Impact of Mucolytic Agents on COPD Exacerbations: A Pair-wise and Network Meta-analysis.
    COPD, 2017, Volume: 14, Issue:5

    Topics: Acetylcysteine; Ambroxol; Carbocysteine; Disease Progression; Expectorants; Humans; Network Meta-Ana

2017

Trials

1 trial available for ambroxol and Disease Exacerbation

ArticleYear
[Effect of mucolytic therapy on the production of reactive oxygen species in the blood of patients with an exacerbation of chronic obstructive pulmonary disease].
    Terapevticheskii arkhiv, 2010, Volume: 82, Issue:3

    Topics: Ambroxol; Disease Progression; Drug Therapy, Combination; Expectorants; Female; Humans; Male; Middle

2010